Financing, Equity Capital Markets
Madrigal Pharmaceuticals, Inc.
09/23
|
$499.9 Million
![Magrigal](/sites/default/files/images/custom/Madrigal-Pharmaceuticals.png)
Piper Sandler served as bookrunner for Madrigal Pharmaceuticals, Inc. on a confidentially marketed follow-on offering